{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:53:59Z","timestamp":1790974439869,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01767-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:12:19Z","timestamp":1774923139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liquid Biopsy in Uterine Leiomyosarcoma: Current Biomarkers, Emerging Technologies, and Future Perspectives"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1512-2041","authenticated-orcid":false,"given":"Danru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-1750","authenticated-orcid":false,"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"2","key":"1767_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","volume":"36","author":"S George","year":"2018","unstructured":"George S, Serrano C, Hensley ML, Ray-Coquard I. Soft tissue and uterine leiomyosarcoma. J Clin Oncol. 2018;36(2):144\u201350.","journal-title":"J Clin Oncol"},{"key":"1767_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13131106","author":"Q Yang","year":"2024","unstructured":"Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, et al. Comprehensive review of uterine leiomyosarcoma: pathogenesis, diagnosis, prognosis, and targeted therapy. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13131106.","journal-title":"Cells"},{"issue":"6","key":"1767_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/clinpract12060094","volume":"12","author":"M Bosoteanu","year":"2022","unstructured":"Bosoteanu M, Deacu M, Voda RI, Orasanu CI, Aschie M, Vlad SE, et al. Five-year retrospective study of uterine STUMP and leiomyosarcoma. Clin Pract. 2022;12(6):897\u2013907.","journal-title":"Clin Pract"},{"key":"1767_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020591","author":"VMC Reichert","year":"2023","unstructured":"Reichert VMC, Alwafai Z, Zygmunt MT, Vollmer M, K\u00f6hler G. Accidental morcellation of uterine leiomyosarcoma influences relapse free survival but does not negatively influence overall survival. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12020591.","journal-title":"J Clin Med"},{"issue":"1","key":"1767_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.6004\/jadpro.2022.13.1.6","volume":"13","author":"KL Byar","year":"2022","unstructured":"Byar KL, Fredericks T. Uterine leiomyosarcoma. J Adv Pract Oncol. 2022;13(1):70\u20136.","journal-title":"J Adv Pract Oncol"},{"key":"1767_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179728","author":"R Spari\u0107","year":"2022","unstructured":"Spari\u0107 R, Andji\u0107 M, Babovi\u0107 I, Nejkovi\u0107 L, Mitrovi\u0107 M, \u0160tuli\u0107 J, et al. Molecular insights in uterine leiomyosarcoma: a systematic review. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179728.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1767_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct Target Ther. 2024;9(1):336.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1767_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2024.11.009","volume":"43","author":"C Alix-Panabi\u00e8res","year":"2025","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Advances in liquid biopsy: from exploration to practical application. Cancer Cell. 2025;43(2):161\u20135.","journal-title":"Cancer Cell"},{"issue":"10","key":"1767_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101198","volume":"4","author":"SM Batool","year":"2023","unstructured":"Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, et al. The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Rep Med. 2023;4(10):101198.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1767_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15(1):131.","journal-title":"J Hematol Oncol"},{"key":"1767_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/s24247902","author":"PM Kalligosfyri","year":"2024","unstructured":"Kalligosfyri PM, Lamprou E, Kalogianni DP. Emerging sensing technologies for liquid biopsy applications: steps closer to personalized medicine. Sensors (Basel). 2024. https:\/\/doi.org\/10.3390\/s24247902.","journal-title":"Sensors (Basel)"},{"issue":"1","key":"1767_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4143\/crt.2024.343","volume":"57","author":"Y Song","year":"2025","unstructured":"Song Y, Li G, Zhang Z, Liu Y, Jia H, Zhang C, et al. Integrated transcriptomic landscape and deep learning based survival prediction in uterine sarcomas. Cancer Res Treat. 2025;57(1):250\u201366.","journal-title":"Cancer Res Treat"},{"issue":"7","key":"1767_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7150\/ijms.93464","volume":"21","author":"J Guo","year":"2024","unstructured":"Guo J, Zheng J, Tong J. Potential markers to differentiate uterine leiomyosarcomas from leiomyomas. Int J Med Sci. 2024;21(7):1227\u201340.","journal-title":"Int J Med Sci"},{"key":"1767_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111217","volume":"170","author":"R Valletta","year":"2024","unstructured":"Valletta R, Corato V, Lombardo F, Avesani G, Negri G, Steinkasserer M, et al. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses. Eur J Radiol. 2024;170:111217.","journal-title":"Eur J Radiol"},{"key":"1767_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081966","author":"K \u017bak","year":"2022","unstructured":"\u017bak K, Zaremba B, Rajtak A, Kotarski J, Amant F, Bobi\u0144ski M. Preoperative differentiation of uterine leiomyomas and leiomyosarcomas: current possibilities and future directions. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14081966.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1767_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.acra.2016.06.004","volume":"23","author":"K Gaetke-Udager","year":"2016","unstructured":"Gaetke-Udager K, McLean K, Sciallis AP, Alves T, Maturen KE, Mervak BM, et al. Diagnostic accuracy of ultrasound, contrast-enhanced CT, and conventional MRI for differentiating leiomyoma from leiomyosarcoma. Acad Radiol. 2016;23(10):1290\u20137.","journal-title":"Acad Radiol"},{"issue":"5","key":"1767_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/CCO.0000000000000758","volume":"33","author":"P Causa Andrieu","year":"2021","unstructured":"Causa Andrieu P, Woo S, Kim TH, Kertowidjojo E, Hodgson A, Sun S. New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions. Curr Opin Oncol. 2021;33(5):464\u201375.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"1767_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13396-y","volume":"25","author":"M Vollmer","year":"2025","unstructured":"Vollmer M, K\u00f6hler G, Radosa JC, Zygmunt M, Zimmermann J, K\u00f6ller M, et al. Validation of biomarkers and clinical scores for the detection of uterine leiomyosarcoma: a case-control study with an update of pLMS. BMC Cancer. 2025;25(1):33.","journal-title":"BMC Cancer"},{"issue":"4","key":"1767_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2022.100084","volume":"36","author":"A Momeni-Boroujeni","year":"2023","unstructured":"Momeni-Boroujeni A, Yousefi E, Balakrishnan R, Riviere S, Kertowidjojo E, Hensley ML, et al. Molecular-based immunohistochemical algorithm for uterine leiomyosarcoma diagnosis. Mod Pathol. 2023;36(4):100084.","journal-title":"Mod Pathol"},{"key":"1767_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ygyno.2023.07.020","volume":"177","author":"D Nasioudis","year":"2023","unstructured":"Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Martin L, et al. Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecol Oncol. 2023;177:14\u20139.","journal-title":"Gynecol Oncol"},{"key":"1767_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081934","author":"F Ciccarone","year":"2022","unstructured":"Ciccarone F, Bruno M, De Paolis E, Piermattei A, De Bonis M, Lorusso D, et al. Role of homologous recombination repair (HRR) genes in uterine leiomyosarcomas: a retrospective analysis. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14081934.","journal-title":"Cancers (Basel)"},{"issue":"25","key":"1767_CR22","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1200\/JCO.23.00402","volume":"41","author":"M Ingham","year":"2023","unstructured":"Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, et al. Phase II study of olaparib and temozolomide for advanced uterine leiomyosarcoma (NCI Protocol 10250). J Clin Oncol. 2023;41(25):4154\u201363.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1767_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167632","volume":"1871","author":"RM Falcao","year":"2025","unstructured":"Falcao RM, de Souza JES, Gonzalez-Molina J, Mathieson W, Carlson JW, Petta TB. Deep multi-omics integration approach reveals new molecular features of uterine leiomyosarcoma. Biochimica et Biophysica Acta (BBA). 2025;1871(3):167632.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"1767_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104776","volume":"213","author":"R Borea","year":"2025","unstructured":"Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, et al. Cancer in a drop: advances in liquid biopsy in 2024. Crit Rev Oncol Hematol. 2025;213:104776.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"1767_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00817-8","volume":"6","author":"D Lin","year":"2021","unstructured":"Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, et al. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6(1):404.","journal-title":"Signal Transduct Target Ther"},{"key":"1767_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713219","author":"J Dao","year":"2023","unstructured":"Dao J, Conway PJ, Subramani B, Meyyappan D, Russell S, Mahadevan D. Using cfDNA and ctDNA as oncologic markers: a path to clinical validation. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713219.","journal-title":"Int J Mol Sci"},{"key":"1767_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103109","volume":"155","author":"LS Pessoa","year":"2020","unstructured":"Pessoa LS, Heringer M, Ferrer VP. CtDNA as a cancer biomarker: a broad overview. Crit Rev Oncol Hematol. 2020;155:103109.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"1767_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.7150\/ijms.16734","volume":"13","author":"Y Gao","year":"2016","unstructured":"Gao Y, Zhu Y, Yuan Z. Circulating tumor cells and circulating tumor DNA provide new insights into pancreatic cancer. Int J Med Sci. 2016;13(12):902\u201313.","journal-title":"Int J Med Sci"},{"issue":"7","key":"1767_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","volume":"20","author":"R Lawrence","year":"2023","unstructured":"Lawrence R, Watters M, Davies CR, Pantel K, Lu YJ. Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol. 2023;20(7):487\u2013500.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1767_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65562-8","volume":"14","author":"T Theparee","year":"2024","unstructured":"Theparee T, Akroush M, Sabatini LM, Wang V, Mangold KA, Joseph N, et al. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024;14(1):15744.","journal-title":"Sci Rep"},{"issue":"1","key":"1767_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-023-01898-5","volume":"22","author":"M Yue","year":"2023","unstructured":"Yue M, Hu S, Sun H, Tuo B, Jia B, Chen C, et al. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Mol Cancer. 2023;22(1):203.","journal-title":"Mol Cancer"},{"key":"1767_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.06.009","author":"J Lee","year":"2025","unstructured":"Lee J, Chen F, Lopez-Beltran A, Necchi A, Cimadamore A, Spiess PE, et al. Urinary tumor DNA-based liquid biopsy in bladder cancer management: a systematic review. Eur Urol Focus. 2025. https:\/\/doi.org\/10.1016\/j.euf.2025.06.009.","journal-title":"Eur Urol Focus"},{"key":"1767_CR33","doi-asserted-by":"publisher","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12(10) :1416. https:\/\/doi.org\/10.3390\/cells12101416","DOI":"10.3390\/cells12101416"},{"issue":"12","key":"1767_CR34","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.1021\/acsnano.3c00674","volume":"17","author":"Z Yu","year":"2023","unstructured":"Yu Z, Yang Y, Fang W, Hu P, Liu Y, Shi J. Dual tumor exosome biomarker co-recognitions based nanoliquid biopsy for the accurate early diagnosis of pancreatic cancer. ACS Nano. 2023;17(12):11384\u201395.","journal-title":"ACS Nano"},{"key":"1767_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117946","volume":"185","author":"S Saxena","year":"2025","unstructured":"Saxena S, Volpe MC, Agostinis C, Vodret S, Ring NAR, Colliva A, et al. Anti-miRNA therapeutics for uterine fibroids. Biomed Pharmacother. 2025;185:117946.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1767_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5775-1","volume":"19","author":"E Yang","year":"2019","unstructured":"Yang E, Xue L, Li Z, Yi T. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p. BMC Cancer. 2019;19(1):709.","journal-title":"BMC Cancer"},{"issue":"2","key":"1767_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1767_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05562-4","volume":"22","author":"J Zhang","year":"2024","unstructured":"Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C. CircRNA as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities. J Transl Med. 2024;22(1):752.","journal-title":"J Transl Med"},{"issue":"4","key":"1767_CR39","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869-81.e13.","journal-title":"Cell"},{"issue":"11","key":"1767_CR40","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1158\/1078-0432.CCR-17-3704","volume":"24","author":"J Przybyl","year":"2018","unstructured":"Przybyl J, Chabon JJ, Spans L, Ganjoo KN, Vennam S, Newman AM, et al. Combination approach for detecting different types of alterations in circulating tumor DNA in Leiomyosarcoma. Clin Cancer Res. 2018;24(11):2688\u201399.","journal-title":"Clin Cancer Res"},{"key":"1767_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ygyno.2023.12.025","volume":"182","author":"F Recio","year":"2024","unstructured":"Recio F, Scalise CB, Loar P, Lumish M, Berman T, Peddada A, et al. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. Gynecol Oncol. 2024;182:63\u20139.","journal-title":"Gynecol Oncol"},{"key":"1767_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010157","author":"M Zhou","year":"2022","unstructured":"Zhou M, Bui N, Rathore R, Sudhaman S, George GV, Malashevich AK, et al. Feasibility of longitudinal ctDNA assessment in patients with uterine and extra-uterine leiomyosarcoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers15010157.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1767_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.36401\/JIPO-20-3","volume":"3","author":"J Arshad","year":"2020","unstructured":"Arshad J, Barreto-Coelho P, Jonczak E, Espejo A, D\u2019Amato G, Trent JC. Identification of genetic alterations by circulating tumor DNA in leiomyosarcoma: a molecular analysis of 73 patients. J Immunother Precis Oncol. 2020;3(2):64\u20138.","journal-title":"J Immunother Precis Oncol"},{"issue":"2","key":"1767_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/IGC.0000000000000037","volume":"24","author":"J Trovik","year":"2014","unstructured":"Trovik J, Salvesen HB, Cuppens T, Amant F, Staff AC. Growth differentiation factor-15 as biomarker in uterine sarcomas. Int J Gynecol Cancer. 2014;24(2):252\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"1767_CR45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/1878-0261.13440","volume":"18","author":"J Gonzalez-Molina","year":"2024","unstructured":"Gonzalez-Molina J, Hahn P, Falc\u00e3o RM, Gultekin O, Kokaraki G, Zanfagnin V, et al. MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness. Mol Oncol. 2024;18(4):850\u201365.","journal-title":"Mol Oncol"},{"issue":"1","key":"1767_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/ijgc-00009577-200601000-00038","volume":"16","author":"B Melichar","year":"2006","unstructured":"Melichar B, Solichov\u00e1 D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer. 2006;16(1):240\u201352.","journal-title":"Int J Gynecol Cancer"},{"key":"1767_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092898","author":"MJ Jeong","year":"2020","unstructured":"Jeong MJ, Park JH, Hur SY, Kim CJ, Nam HS, Lee YS. Preoperative neutrophil-to-lymphocyte ratio as a prognostic factor in uterine sarcoma. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9092898.","journal-title":"J Clin Med"},{"issue":"11","key":"1767_CR48","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/ijc.35310","volume":"156","author":"AG Simon","year":"2025","unstructured":"Simon AG, Lyu SI, Schultheis AM, Stahl D, Wuerdemann N, Walter S, et al. Exploration of histone protein \u03b3-H2AX as a prognostic factor in soft tissue sarcomas and its association with biological behavior, immune cell environment and survival in leiomyosarcoma. Int J Cancer. 2025;156(11):2237\u201350.","journal-title":"Int J Cancer"},{"issue":"9b","key":"1767_CR49","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1111\/j.1582-4934.2008.00541.x","volume":"13","author":"G Shi","year":"2009","unstructured":"Shi G, Perle MA, Mittal K, Chen H, Zou X, Narita M, et al. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma. J Cell Mol Med. 2009;13(9b):3898\u2013905.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1767_CR50","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2353\/ajpath.2010.091150","volume":"177","author":"LS Danielson","year":"2010","unstructured":"Danielson LS, Menendez S, Attolini CS, Guijarro MV, Bisogna M, Wei J, et al. A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol. 2010;177(2):908\u201317.","journal-title":"Am J Pathol"},{"issue":"5","key":"1767_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ygeno.2012.03.003","volume":"99","author":"B Georgieva","year":"2012","unstructured":"Georgieva B, Milev I, Minkov I, Dimitrova I, Bradford AP, Baev V. Characterization of the uterine leiomyoma microRNAome by deep sequencing. Genomics. 2012;99(5):275\u201381.","journal-title":"Genomics"},{"issue":"12","key":"1767_CR52","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1111\/cas.14215","volume":"110","author":"A Yokoi","year":"2019","unstructured":"Yokoi A, Matsuzaki J, Yamamoto Y, Tate K, Yoneoka Y, Shimizu H, et al. Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma. Cancer Sci. 2019;110(12):3718\u201326.","journal-title":"Cancer Sci"},{"issue":"4","key":"1767_CR53","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s13277-013-0748-5","volume":"34","author":"M Kowalewska","year":"2013","unstructured":"Kowalewska M, Bakula-Zalewska E, Chechlinska M, Goryca K, Nasierowska-Guttmejer A, Danska-Bidzinska A, et al. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report. Tumour Biol. 2013;34(4):2153\u201360.","journal-title":"Tumour Biol"},{"issue":"3","key":"1767_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ygyno.2016.01.001","volume":"140","author":"Y Ravid","year":"2016","unstructured":"Ravid Y, Formanski M, Smith Y, Reich R, Davidson B. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecol Oncol. 2016;140(3):512\u20137.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1767_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1933719114553450","volume":"22","author":"TD Chuang","year":"2015","unstructured":"Chuang TD, Ho M, Khorram O. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line. Reprod Sci. 2015;22(5):563\u201371.","journal-title":"Reprod Sci"},{"key":"1767_CR56","doi-asserted-by":"publisher","unstructured":"de Almeida BC, Garcia N, Maffazioli G, dos Anjos LG, Baracat EC, Carvalho KC. Oncomirs expression profiling in uterine leiomyosarcoma cells. Int J Mol Sci. 2017;19(1) :52. https:\/\/doi.org\/10.3390\/ijms19010052","DOI":"10.3390\/ijms19010052"},{"issue":"3","key":"1767_CR57","first-page":"1547","volume":"38","author":"MB Stope","year":"2018","unstructured":"Stope MB, Cernat V, Kaul A, Diesing K, Koensgen D, Burchardt M, et al. Functionality of the tumor suppressor microRNA-1 in malignant tissue and cell line cells of uterine leiomyosarcoma. Anticancer Res. 2018;38(3):1547\u201350.","journal-title":"Anticancer Res"},{"issue":"1","key":"1767_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09674845.2017.1340225","volume":"75","author":"X Tong","year":"2018","unstructured":"Tong X, Wang X, Wang C, Li L. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. Br J Biomed Sci. 2018;75(1):7\u201312.","journal-title":"Br J Biomed Sci"},{"key":"1767_CR59","doi-asserted-by":"publisher","unstructured":"de Almeida BC, Dos Anjos LG, Uno M, Cunha IWD, Soares FA, Baiocchi G, et al. Let-7 miRNA's expression profile and its potential prognostic role in uterine leiomyosarcoma. Cells. 2019;8(11) :1452. https:\/\/doi.org\/10.3390\/cells8111452","DOI":"10.3390\/cells8111452"},{"key":"1767_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142160","author":"Q Yang","year":"2022","unstructured":"Yang Q, Bariani MV, Falahati A, Khosh A, Lastra RR, Siblini H, et al. The functional role and regulatory mechanism of bromodomain-containing protein 9 in human uterine leiomyosarcoma. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11142160.","journal-title":"Cells"},{"key":"1767_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092420","author":"I Psilopatis","year":"2023","unstructured":"Psilopatis I, Vrettou K, Kokkali S, Theocharis S. The role of microRNAs in uterine leiomyosarcoma diagnosis and treatment. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15092420.","journal-title":"Cancers (Basel)"},{"key":"1767_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097957","author":"Q Yang","year":"2023","unstructured":"Yang Q, Al-Hendy A. The functional role and regulatory mechanism of FTO m(6)A RNA demethylase in human uterine leiomyosarcoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097957.","journal-title":"Int J Mol Sci"},{"key":"1767_CR63","doi-asserted-by":"publisher","DOI":"10.3892\/or.2023.8523","author":"K Yoshida","year":"2023","unstructured":"Yoshida K, Yokoi A, Kitagawa M, Sugiyama M, Yamamoto T, Nakayama J, et al. Downregulation of miR\u201110b\u20115p facilitates the proliferation of uterine leiomyosarcoma cells: a microRNA sequencing\u2011based approach. Oncol Rep. 2023. https:\/\/doi.org\/10.3892\/or.2023.8523.","journal-title":"Oncol Rep"},{"key":"1767_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100350","volume":"79","author":"TG de Almeida","year":"2024","unstructured":"de Almeida TG, Ricci AR, Dos Anjos LG, Soares Junior JM, Maciel GAR, Baracat EC, et al. FOXO3a deregulation in uterine smooth muscle tumors. Clinics (Sao Paulo). 2024;79:100350.","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"1767_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167103","volume":"1870","author":"Y Nagao","year":"2024","unstructured":"Nagao Y, Yokoi A, Yoshida K, Kitagawa M, Asano-Inami E, Kato T, et al. Uterine leiomyosarcoma cell-derived extracellular vesicles induce the formation of cancer-associated fibroblasts. Biochim Biophys Acta Mol Basis Dis. 2024;1870(4):167103.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"1767_CR66","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.diii.2019.07.007","volume":"100","author":"S Sun","year":"2019","unstructured":"Sun S, Bonaffini PA, Nougaret S, Fournier L, Dohan A, Chong J, et al. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging. Diagn Interv Imaging. 2019;100(10):619\u201334.","journal-title":"Diagn Interv Imaging"},{"issue":"1125","key":"1767_CR67","doi-asserted-by":"publisher","first-page":"20210283","DOI":"10.1259\/bjr.20210283","volume":"94","author":"V Bura","year":"2021","unstructured":"Bura V, Pintican RM, David RE, Addley HC, Smith J, Jimenez-Linan M, et al. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants. Br J Radiol. 2021;94(1125):20210283.","journal-title":"Br J Radiol"},{"issue":"5","key":"1767_CR68","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s00261-024-04198-8","volume":"49","author":"LA Roller","year":"2024","unstructured":"Roller LA, Wan Q, Liu X, Qin L, Chapel D, Burk KS, et al. MRI, clinical, and radiomic models for differentiation of uterine leiomyosarcoma and leiomyoma. Abdom Radiol (NY). 2024;49(5):1522\u201333.","journal-title":"Abdom Radiol (NY)"},{"key":"1767_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejrad.2019.04.004","volume":"115","author":"H Xie","year":"2019","unstructured":"Xie H, Hu J, Zhang X, Ma S, Liu Y, Wang X. Preliminary utilization of radiomics in differentiating uterine sarcoma from atypical leiomyoma: comparison on diagnostic efficacy of MRI features and radiomic features. Eur J Radiol. 2019;115:39\u201345.","journal-title":"Eur J Radiol"},{"issue":"1","key":"1767_CR70","doi-asserted-by":"publisher","DOI":"10.5334\/jbsr.2275","volume":"104","author":"M Virarkar","year":"2020","unstructured":"Virarkar M, Diab R, Palmquist S, Bassett R Jr., Bhosale P. Diagnostic performance of MRI to differentiate uterine leiomyosarcoma from benign leiomyoma: a meta-analysis. J Belg Soc Radiol. 2020;104(1):69.","journal-title":"J Belg Soc Radiol"},{"issue":"11","key":"1767_CR71","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1007\/s00330-022-08783-7","volume":"32","author":"M Dai","year":"2022","unstructured":"Dai M, Liu Y, Hu Y, Li G, Zhang J, Xiao Z, et al. Combining multiparametric MRI features-based transfer learning and clinical parameters: application of machine learning for the differentiation of uterine sarcomas from atypical leiomyomas. Eur Radiol. 2022;32(11):7988\u201397.","journal-title":"Eur Radiol"},{"key":"1767_CR72","doi-asserted-by":"crossref","unstructured":"Mas A, Alonso R, Garrido-G\u00f3mez T, Escorcia P, Montero B, Jim\u00e9nez-Almaz\u00e1n J, et al. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing. Am J Obstet Gynecol. 2019;221(4):320.e1-.e23.","DOI":"10.1016\/j.ajog.2019.05.018"},{"key":"1767_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-025-01893-9","author":"EN Paul","year":"2025","unstructured":"Paul EN, Carpenter TJ, Bossick A, Allo G, Wegienka GR, Teixeira JM. The human myometrial transcriptome and the DNA methylome of testosterone-treated patients resemble the myometria from fibroid patients. Reprod Sci. 2025. https:\/\/doi.org\/10.1007\/s43032-025-01893-9.","journal-title":"Reprod Sci"},{"key":"1767_CR74","doi-asserted-by":"publisher","DOI":"10.1200\/po.18.00409","author":"J Przybyl","year":"2019","unstructured":"Przybyl J, Spans L, Lum DA, Zhu S, Vennam S, Forg\u00f3 E, et al. Detection of circulating tumor DNA in patients with uterine leiomyomas. JCO Precis Oncol. 2019. https:\/\/doi.org\/10.1200\/po.18.00409.","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"1767_CR75","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/uog.23763","volume":"59","author":"F Scott","year":"2022","unstructured":"Scott F, Menezes M, Smet ME, Carey K, Hardy T, Fullston T, et al. Influence of fibroids on cell-free DNA screening accuracy. Ultrasound Obstet Gynecol. 2022;59(1):114\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"1767_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/AOG.0000000000005504","volume":"143","author":"TR Kolarova","year":"2024","unstructured":"Kolarova TR, Alderson A, MacKinnon H, Chen L, Buchan JG, Lockwood C, et al. Effect of uterine leiomyomas on noninvasive prenatal testing parameters in the first trimester. Obstet Gynecol. 2024;143(3):456\u20138.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1767_CR77","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/uog.29098","volume":"64","author":"DL Rolnik","year":"2024","unstructured":"Rolnik DL, Raymond Y, Lee T, Ramkrishna J, da Silva Costa F, Menezes M, et al. Uterine fibroids and non-informative cell-free DNA screening results. Ultrasound Obstet Gynecol. 2024;64(4):463\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1767_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050577","author":"A Navarro","year":"2022","unstructured":"Navarro A, Bariani MV, Park HS, Zota AR, Al-Hendy A. Report of exosomes isolated from a human uterine leiomyoma cell line and their impact on endometrial vascular endothelial cells. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15050577.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"1767_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23114","volume":"34","author":"E Fazeli","year":"2020","unstructured":"Fazeli E, Piltan S, Sadeghi H, Gholami M, Azizi-Tabesh G, Yassaee F, et al. Ectopic expression of CYP24A1 circular RNA hsa_circ_0060927 in uterine leiomyomas. J Clin Lab Anal. 2020;34(4):e23114.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"1767_CR80","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2018.01.034","volume":"109","author":"TD Chuang","year":"2018","unstructured":"Chuang TD, Xie Y, Yan W, Khorram O. Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma. Fertil Steril. 2018;109(5):919\u201329.","journal-title":"Fertil Steril"},{"key":"1767_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041688","author":"TD Chuang","year":"2025","unstructured":"Chuang TD, Ton N, Rysling S, Baghdasarian D, Khorram O. Differential expression of small non-coding RNAs in uterine leiomyomas. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26041688.","journal-title":"Int J Mol Sci"},{"key":"1767_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021307","author":"TD Chuang","year":"2024","unstructured":"Chuang TD, Ton N, Rysling S, Boos D, Khorram O. The effect of race\/ethnicity and MED12 mutation on the expression of long non-coding RNAs in uterine leiomyoma and myometrium. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25021307.","journal-title":"Int J Mol Sci"},{"key":"1767_CR83","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/IJWH.S211632","volume":"11","author":"M Akbari","year":"2019","unstructured":"Akbari M, Yassaee F, Aminbeidokhti M, Abedin-Do A, Mirfakhraie R. LncRNA SRA1 may play a role in the uterine leiomyoma tumor growth regarding the MED12 mutation pattern. Int J Womens Health. 2019;11:495\u2013500.","journal-title":"Int J Womens Health"},{"issue":"27","key":"1767_CR84","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/s41388-019-0808-4","volume":"38","author":"T Cao","year":"2019","unstructured":"Cao T, Jiang Y, Wang Z, Zhang N, Al-Hendy A, Mamillapalli R, et al. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas. Oncogene. 2019;38(27):5356\u201366.","journal-title":"Oncogene"},{"key":"1767_CR85","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2671","volume":"76","author":"X Zhan","year":"2021","unstructured":"Zhan X, Zhou H, Sun Y, Shen B, Chou D. Long non-coding ribonucleic acid H19 and ten-eleven translocation enzyme 1 messenger RNA expression levels in uterine fibroids may predict their postoperative recurrence. Clinics (Sao Paulo). 2021;76:e2671.","journal-title":"Clinics (Sao Paulo)"},{"issue":"21","key":"1767_CR86","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401982R","volume":"38","author":"TD Chuang","year":"2024","unstructured":"Chuang TD, Ton N, Rysling S, Khorram O. The in vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression. FASEB J. 2024;38(21):e70140.","journal-title":"FASEB J"},{"issue":"12","key":"1767_CR87","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1042\/CS20240190","volume":"138","author":"TD Chuang","year":"2024","unstructured":"Chuang TD, Ton N, Manrique N, Rysling S, Khorram O. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clin Sci Lond. 2024;138(12):699\u2013709.","journal-title":"Clin Sci Lond"},{"issue":"1","key":"1767_CR88","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.fertnstert.2020.07.024","volume":"115","author":"TD Chuang","year":"2021","unstructured":"Chuang TD, Rehan A, Khorram O. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 2021;115(1):238\u201347.","journal-title":"Fertil Steril"},{"key":"1767_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111539","author":"TD Chuang","year":"2024","unstructured":"Chuang TD, Ton N, Rysling S, Khorram O. The functional role of the long non-coding RNA LINCMD1 in leiomyoma pathogenesis. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111539.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1767_CR90","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","volume":"89","author":"EE Marsh","year":"2008","unstructured":"Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, Bulun SE. Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril. 2008;89(6):1771\u20136.","journal-title":"Fertil Steril"},{"key":"1767_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21083016","author":"M Ciebiera","year":"2020","unstructured":"Ciebiera M, W\u0142odarczyk M, Zgliczy\u0144ski S, \u0141ozi\u0144ski T, Walczak K, Czekierdowski A. The role of miRNA and related pathways in pathophysiology of uterine fibroids-from bench to bedside. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21083016.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1767_CR92","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.fertnstert.2019.12.002","volume":"113","author":"TD Chuang","year":"2020","unstructured":"Chuang TD, Rehan A, Khorram O. Tranilast induces MiR-200c expression through blockade of RelA\/p65 activity in leiomyoma smooth muscle cells. Fertil Steril. 2020;113(6):1308\u201318.","journal-title":"Fertil Steril"},{"issue":"6","key":"1767_CR93","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.fertnstert.2020.04.011","volume":"113","author":"M Ali","year":"2020","unstructured":"Ali M, Esfandyari S, Al-Hendy A. Evolving role of microRNAs in uterine fibroid pathogenesis: filling the gap! Fertil Steril. 2020;113(6):1167\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"1767_CR94","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.fertnstert.2019.08.067","volume":"112","author":"SG Vitale","year":"2019","unstructured":"Vitale SG, Valenti G, Cianci A. Crosstalk between transforming growth factor-\u03b23 and microRNA-29c in leiomyoma: are we stepping forward? Fertil Steril. 2019;112(6):1055\u20136.","journal-title":"Fertil Steril"},{"issue":"5","key":"1767_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268793","volume":"17","author":"M Kim","year":"2022","unstructured":"Kim M, Kang D, Kwon MY, Lee HJ, Kim MJ. MicroRNAs as potential indicators of the development and progression of uterine leiomyoma. PLoS ONE. 2022;17(5):e0268793.","journal-title":"PLoS ONE"},{"key":"1767_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/genes13071106","author":"M Di Vincenzo","year":"2022","unstructured":"Di Vincenzo M, De Quattro C, Rossato M, Lazzarini R, Delli Carpini G, Ciavattini A, et al. A possible cause for the differential expression of a subset of miRNAs in mesenchymal stem cells derived from myometrium and leiomyoma. Genes. 2022. https:\/\/doi.org\/10.3390\/genes13071106.","journal-title":"Genes"},{"key":"1767_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1084192","volume":"12","author":"Y Ke","year":"2022","unstructured":"Ke Y, You L, Xu Y, Wu D, Lin Q, Wu Z. DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma. Front Oncol. 2022;12:1084192.","journal-title":"Front Oncol"},{"key":"1767_CR98","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012020","author":"S Movva","year":"2025","unstructured":"Movva S, Seier K, Bradic M, Charalambous K, Rosenbaum E, Kelly CM, et al. Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-012020.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1767_CR99","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2024.2418426","volume":"41","author":"WC Chen","year":"2024","unstructured":"Chen WC, Chang TC, Perera L, Cheng MH, Hong JJ, Cheng CM. Pilot study on the impact of HIFU treatment on miRNA profiles in vaginal secretions of uterine fibroids and adenomyosis patients. Int J Hyperthermia. 2024;41(1):2418426.","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"1767_CR100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/gcc.22906","volume":"60","author":"S Croce","year":"2021","unstructured":"Croce S, Chibon F. Molecular prognostication of uterine smooth muscle neoplasms: from CGH array to CINSARC signature and beyond. Genes Chromosomes Cancer. 2021;60(3):129\u201337.","journal-title":"Genes Chromosomes Cancer"},{"key":"1767_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/bios15060360","author":"K Du","year":"2025","unstructured":"Du K, Zeng Q, Jiang M, Hu Z, Zhou M, Xia K. CRISPR\/Cas12a-based biosensing: advances in mechanisms and applications for nucleic acid detection. Biosensors. 2025. https:\/\/doi.org\/10.3390\/bios15060360.","journal-title":"Biosensors"},{"issue":"25","key":"1767_CR102","doi-asserted-by":"publisher","first-page":"13504","DOI":"10.1021\/acs.analchem.5c01953","volume":"97","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yang S, Chen X, Song S, Wu Y, Li Y, et al. Mutually activated dual-exponential amplification DNA machine enhances robust CRISPR\/Cas12a feedback propagation for ultrasensitive miRNA detection. Anal Chem. 2025;97(25):13504\u201313.","journal-title":"Anal Chem"},{"key":"1767_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252010902","author":"I Palac\u00edn-Aliana","year":"2024","unstructured":"Palac\u00edn-Aliana I, Garc\u00eda-Romero N, Carri\u00f3n-Navarro J, Puig-Serra P, Torres-Ruiz R, Rodr\u00edguez-Perales S, et al. ddPCR overcomes the CRISPR-Cas13a-based technique for the detection of the BRAF p.V600E mutation in liquid biopsies. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252010902.","journal-title":"Int J Mol Sci"},{"issue":"45","key":"1767_CR104","doi-asserted-by":"publisher","first-page":"16692","DOI":"10.1021\/acs.analchem.3c03460","volume":"95","author":"C Escalona-Noguero","year":"2023","unstructured":"Escalona-Noguero C, Alarc\u00f3n-Iniesta H, L\u00f3pez-Valls M, Del Carpio LP, Piulats JM, Somoza \u00c1, et al. Detection of the uveal melanoma-associated mutation GNAQ Q209P from liquid biopsy using CRISPR\/Cas12a technology. Anal Chem. 2023;95(45):16692\u2013700.","journal-title":"Anal Chem"},{"key":"1767_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2024.126780","volume":"280","author":"SF Song","year":"2024","unstructured":"Song SF, Zhang XW, Chen S, Shu Y, Yu YL, Wang JH. CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis. Talanta. 2024;280:126780.","journal-title":"Talanta"},{"issue":"7","key":"1767_CR106","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1021\/acs.nanolett.3c04828","volume":"24","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Gao X, Ho YP, Liu M, Han Y, Li DL, et al. Controllable assembly of a quantum dot-based aptasensor guided by CRISPR\/Cas12a for direct measurement of circulating tumor cells in human blood. Nano Lett. 2024;24(7):2360\u20138.","journal-title":"Nano Lett"},{"issue":"1","key":"1767_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s40580-021-00263-w","volume":"8","author":"DP Kalogianni","year":"2021","unstructured":"Kalogianni DP. Nanotechnology in emerging liquid biopsy applications. Nano Converg. 2021;8(1):13.","journal-title":"Nano Converg"},{"issue":"2","key":"1767_CR108","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/acssensors.4c03180","volume":"10","author":"X Yuan","year":"2025","unstructured":"Yuan X, Geng W, Ji J, Yan Z, Wei J, Wu Y, et al. CRISPR\/Cas13a-programmed Cu NCs and Z-scheme T-COF\/Ag(2)S for photoelectrochemical biosensing of circRNA. ACS Sens. 2025;10(2):1270\u20139.","journal-title":"ACS Sens"},{"key":"1767_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117236","volume":"275","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang B, Wu X, Wang F, Yang Z, Li M, et al. A facile liquid biopsy assay for highly efficient CTCs capture and reagent-less monitoring of immune checkpoint PD-L1 expression on CTCs with non-small cell lung cancer patients. Biosens Bioelectron. 2025;275:117236.","journal-title":"Biosens Bioelectron"},{"issue":"11","key":"1767_CR110","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1021\/acsabm.2c00393","volume":"5","author":"M Rahman","year":"2022","unstructured":"Rahman M, Niu J, Cui X, Zhou C, Tang N, Jin H, et al. Electrochemical biosensor based on l-arginine and rGO-AuNSs deposited on the electrode combined with DNA probes for ultrasensitive detection of the gastric cancer-related PIK3CA gene of ctDNA. ACS Appl Bio Mater. 2022;5(11):5094\u2013103.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"1767_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01684-9","volume":"21","author":"T Guo","year":"2022","unstructured":"Guo T, Tang XH, Gao XY, Zhou Y, Jin B, Deng ZQ, et al. A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer. Mol Cancer. 2022;21(1):216.","journal-title":"Mol Cancer"},{"key":"1767_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13152484","author":"X Yu","year":"2023","unstructured":"Yu X, Lei X. Application of the multi-omics liquid biopsy method M2P-HCC in early liver cancer screening for high-risk individuals with hepatitis B-related liver cancer. Diagnostics. 2023. https:\/\/doi.org\/10.3390\/diagnostics13152484.","journal-title":"Diagnostics"},{"issue":"1","key":"1767_CR113","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","volume":"79","author":"A Lapitz","year":"2023","unstructured":"Lapitz A, Azkargorta M, Milkiewicz P, Olaizola P, Zhuravleva E, Grimsrud MM, et al. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma. J Hepatol. 2023;79(1):93\u2013108.","journal-title":"J Hepatol"},{"issue":"11","key":"1767_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101281","volume":"4","author":"Y Tao","year":"2023","unstructured":"Tao Y, Xing S, Zuo S, Bao P, Jin Y, Li Y, et al. Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood. Cell Rep Med. 2023;4(11):101281.","journal-title":"Cell Rep Med"},{"key":"1767_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042190","author":"A Machado-Lopez","year":"2022","unstructured":"Machado-Lopez A, Alonso R, Lago V, Jimenez-Almazan J, Garcia M, Monleon J, et al. Integrative genomic and transcriptomic profiling reveals a differential molecular signature in uterine leiomyoma versus leiomyosarcoma. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23042190.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1767_CR116","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/clinchem\/hvab116","volume":"67","author":"JSL Vong","year":"2021","unstructured":"Vong JSL, Ji L, Heung MMS, Cheng SH, Wong J, Lai PBS, et al. Single cell and plasma RNA sequencing for RNA liquid biopsy for hepatocellular carcinoma. Clin Chem. 2021;67(11):1492\u2013502.","journal-title":"Clin Chem"},{"issue":"1","key":"1767_CR117","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41467-024-55140-x","volume":"16","author":"A Mishra","year":"2025","unstructured":"Mishra A, Huang SB, Dubash T, Burr R, Edd JF, Wittner BS, et al. Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nat Commun. 2025;16(1):32.","journal-title":"Nat Commun"},{"key":"1767_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2025.102004","volume":"75","author":"SY Yan","year":"2025","unstructured":"Yan SY, Fu XY, Yang Y, Jia LY, Liang JW, Li YH, et al. Artificial intelligence in early screening for esophageal squamous cell carcinoma. Best Pract Res Clin Gastroenterol. 2025;75:102004.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"1767_CR119","doi-asserted-by":"publisher","DOI":"10.1063\/5.0153413","volume":"7","author":"F Borrelli","year":"2023","unstructured":"Borrelli F, Behal J, Cohen A, Miccio L, Memmolo P, Kurelac I, et al. AI-aided holographic flow cytometry for label-free identification of ovarian cancer cells in the presence of unbalanced datasets. APL Bioeng. 2023;7(2):026110.","journal-title":"APL Bioeng"},{"key":"1767_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093166","author":"K Yanagisawa","year":"2020","unstructured":"Yanagisawa K, Toratani M, Asai A, Konno M, Niioka H, Mizushima T, et al. Convolutional neural network can recognize drug resistance of single cancer cells. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093166.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1767_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47805-2","volume":"13","author":"S Albaradei","year":"2023","unstructured":"Albaradei S, Alganmi N, Albaradie A, Alharbi E, Motwalli O, Thafar MA, et al. A deep learning model predicts the presence of diverse cancer types using circulating tumor cells. Sci Rep. 2023;13(1):21114.","journal-title":"Sci Rep"},{"key":"1767_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120484","volume":"577","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Rejili M, Khan A, Alshammari SO, Tan CS, Haouala F, et al. AI-powered liquid biopsy for early detection of gastrointestinal cancers. Clin Chim Acta. 2025;577:120484.","journal-title":"Clin Chim Acta"},{"key":"1767_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153785","author":"T Zehra","year":"2022","unstructured":"Zehra T, Anjum S, Mahmood T, Shams M, Sultan BA, Ahmad Z, et al. A novel deep learning-based mitosis recognition approach and dataset for uterine leiomyosarcoma histopathology. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14153785.","journal-title":"Cancers (Basel)"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01767-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:20:28Z","timestamp":1774930828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01767-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01767-6","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This article does not contain any studies with\u00a0human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent\u00a0"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"34"}}